+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030- Product Image
Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030- Product Image
New

Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 5990709
Description Jump to:
The Molecular Imaging Market was valued at USD 8.8 Billion in 2024, and is projected to reach USD 11.4 Billion by 2030, rising at a CAGR of 4.60%. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights

  • Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.3% in 2024
  • The Nuclear Magnetic Resonance (NMR) spectrometer segment is anticipated to be the fastest-growing segment, with a CAGR of 8.8% from 2025 to 2030.
  • Based on application, Oncology segment accounted for the largest market share in 2024 due to the rising global cancer burden and the growing demand for advanced diagnostic solutions.
  • Based on end use, Hospitals segment held the largest market share in 2024 due to the increasing adoption of advanced imaging technologies in clinical settings.
  • The diagnostic imaging centers segment is projected to be the fastest-growing segment over the forecast period, driven by the ability to offer high-quality, specialized imaging procedures with efficient turnaround times compared to larger hospitals.
  • North America dominated the market with a share of 41. 4% in 2024.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Application
1.2.3. End Use
1.2.4. Regional Scope
1.2.5. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality Outlook
2.2.2. Application Outlook
2.2.3. End Use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Molecular Imaging Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Molecular Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis
4.1. Modality Segment Dashboard
4.2. Molecular Imaging Market: Modality Movement Analysis
4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. Molecular Ultrasound Imaging
4.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5. Positron Emission Tomography (PET)
4.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6. Single Photon Emission Computed Tomography (SPECT)
4.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
4.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Molecular Imaging Market: Application Movement Analysis
5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiovascular
5.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5. Neurology
5.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.6. Oncology
5.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.7. Respiratory
5.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.8. Gastrointestinal
5.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis
6.1. End Use Segment Dashboard
6.2. Molecular Imaging Market: End Use Movement Analysis
6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
6.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6. Research Institutes
6.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Molecular Imaging Market by Region: Key Takeaways
7.4. North America
7.4.1. U.S.
7.4.1.1. Key Country Dynamics
7.4.1.2. Regulatory Framework/ Reimbursement Structure
7.4.1.3. Competitive Scenario
7.4.1.4. U.S. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework/ Reimbursement Structure
7.4.2.3. Competitive Scenario
7.4.2.4. Canada Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework/ Reimbursement Structure
7.4.3.3. Competitive Scenario
7.4.3.4. Mexico Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. U.K.
7.5.1.1. Key Country Dynamics
7.5.1.2. Regulatory Framework/ Reimbursement Structure
7.5.1.3. Competitive Scenario
7.5.1.4. U.K. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework/ Reimbursement Structure
7.5.2.3. Competitive Scenario
7.5.2.4. Germany Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework/ Reimbursement Structure
7.5.3.3. Competitive Scenario
7.5.3.4. France Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework/ Reimbursement Structure
7.5.4.3. Competitive Scenario
7.5.4.4. Italy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework/ Reimbursement Structure
7.5.5.3. Competitive Scenario
7.5.5.4. Spain Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.6. Denmark
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework/ Reimbursement Structure
7.5.6.3. Competitive Scenario
7.5.6.4. Denmark Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework/ Reimbursement Structure
7.5.7.3. Competitive Scenario
7.5.7.4. Sweden Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5.8. Norway
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework/ Reimbursement Structure
7.5.8.3. Competitive Scenario
7.5.8.4. Norway Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key Country Dynamics
7.6.1.2. Regulatory Framework/ Reimbursement Structure
7.6.1.3. Competitive Scenario
7.6.1.4. Japan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework/ Reimbursement Structure
7.6.2.3. Competitive Scenario
7.6.2.4. China Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework/ Reimbursement Structure
7.6.3.3. Competitive Scenario
7.6.3.4. India Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework/ Reimbursement Structure
7.6.4.3. Competitive Scenario
7.6.4.4. Australia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework/ Reimbursement Structure
7.6.5.3. Competitive Scenario
7.6.5.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework/ Reimbursement Structure
7.6.6.3. Competitive Scenario
7.6.6.4. Thailand Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework/ Reimbursement Structure
7.7.2.3. Competitive Scenario
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework/ Reimbursement Structure
7.7.3.3. Competitive Scenario
7.7.3.4. Argentina Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework/ Reimbursement Structure
7.8.2.3. Competitive Scenario
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework/ Reimbursement Structure
7.8.3.3. Competitive Scenario
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework/ Reimbursement Structure
7.8.4.3. Competitive Scenario
7.8.4.4. UAE Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Framework/ Reimbursement Structure
7.8.5.3. Competitive Scenario
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/ Competition Categorization
8.3. Vendor Landscape
8.3.1. Key Company Heat Map Analysis, 2024
8.4. Company Profiles
8.4.1. Bruker
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. GE HealthCare
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Siemens Healthineers AG
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Koninklijke Philips N.V.
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Canon Medical Systems Corporation
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Mediso Ltd.
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Cubresa Inc.
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Shimadzu Corporation
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. United Imaging Healthcare Co., Ltd.
8.4.9.1. Company Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Positron
8.4.10.1. Company Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Molecular Imaging Market, by Region, 2018-2030 (USD Million)
Table 4 Global Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 5 Global Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 6 Global Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 7 North America Molecular Imaging Market, by Country, 2018-2030 (USD Million)
Table 8 North America Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 9 North America Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 10 North America Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 11 U.S. Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 12 U.S. Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 13 U.S. Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 14 Canada Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 15 Canada Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 16 Canada Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 17 Mexico Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 18 Mexico Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 19 Mexico Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 20 Europe Molecular Imaging Market, by Country, 2018-2030 (USD Million)
Table 21 Europe Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 22 Europe Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 23 Europe Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 24 U.K. Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 25 U.K. Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 26 U.K. Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 27 Germany Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 28 Germany Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 29 Germany Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 30 France Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 31 France Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 32 France Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 33 Italy Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 34 Italy Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 35 Italy Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 36 Spain Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 37 Spain Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 38 Spain Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 39 Denmark Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 40 Denmark Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 41 Denmark Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 42 Sweden Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 43 Sweden Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 44 Sweden Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 45 Norway Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 46 Norway Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 47 Norway Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 48 Asia Pacific Molecular Imaging Market, by Country, 2018-2030 (USD Million)
Table 49 Asia Pacific Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 50 Asia Pacific Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 51 Asia Pacific Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 52 Japan Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 53 Japan Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 54 Japan Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 55 China Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 56 China Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 57 China Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 58 India Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 59 India Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 60 India Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 61 Australia Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 62 Australia Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 63 Australia Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 64 South Korea Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 65 South Korea Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 66 South Korea Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 67 Thailand Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 68 Thailand Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 69 Thailand Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 70 Latin America Molecular Imaging Market, by Country, 2018-2030 (USD Million)
Table 71 Latin America Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 72 Latin America Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 73 Latin America Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 74 Brazil Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 75 Brazil Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 76 Brazil Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 77 Argentina Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 78 Argentina Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 79 Argentina Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 80 Middle East & Africa Molecular Imaging Market, by Country, 2018-2030 (USD Million)
Table 81 Middle East & Africa Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 82 Middle East & Africa Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 83 Middle East & Africa Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 84 South Africa Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 85 South Africa Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 86 South Africa Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 87 Saudi Arabia Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 88 Saudi Arabia Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 89 Saudi Arabia Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 90 UAE Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 91 UAE Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 92 UAE Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
Table 93 Kuwait Molecular Imaging Market, by Modality, 2018-2030 (USD Million)
Table 94 Kuwait Molecular Imaging Market, by Application, 2018-2030 (USD Million)
Table 95 Kuwait Molecular Imaging Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Molecular Imaging Market: Market Outlook
Figure 10 Molecular Imaging Competitive Insights
Figure 11 Parent Market Outlook
Figure 12 Related/Ancillary Market Outlook
Figure 13 Penetration and Growth Prospect Mapping
Figure 14 Industry Value Chain Analysis
Figure 15 Molecular Imaging Market Driver Impact
Figure 16 Molecular Imaging Market Restraint Impact
Figure 17 Molecular Imaging Market Strategic Initiatives Analysis
Figure 18 Molecular Imaging Market: Modality Movement Analysis
Figure 19 Molecular Imaging Market: Modality Outlook and Key Takeaways
Figure 20 Molecular Ultrasound Imaging Market Estimates and Forecast, 2018-2030
Figure 21 Positron Emission Tomography (PET) Market Estimates and Forecast, 2018-2030
Figure 22 Single Photon Emission Computed Tomography (SPECT) Market Estimates and Forecast, 2018-2030
Figure 23 Nuclear Magnetic Resonance (NMR) Spectrometer Market Estimates and Forecast, 2018-2030
Figure 24 Others Market Estimates and Forecast, 2018-2030
Figure 25 Molecular Imaging Market: Application Movement Analysis
Figure 26 Molecular Imaging Market: Application Outlook and Key Takeaways
Figure 27 Cardiovascular Market, 2018-2030 (USD Million)
Figure 28 Neurology Market, 2018-2030 (USD Million)
Figure 29 Oncology Market, 2018-2030 (USD Million)
Figure 30 Respiratory Market, 2018-2030 (USD Million)
Figure 31 Gastrointestinal Market, 2018-2030 (USD Million)
Figure 32 Molecular Imaging Market: End Use Movement Analysis
Figure 33 Molecular Imaging Market: End Use Outlook and Key Takeaways
Figure 34 Hospitals Market, 2018-2030 (USD Million)
Figure 35 Diagnostic Imaging Centers Market, 2018-2030 (USD Million)
Figure 36 Research Institutes Market, 2018-2030 (USD Million)
Figure 37 Global Molecular Imaging Market: Regional Movement Analysis
Figure 31 Global Molecular Imaging Market: Regional Outlook and Key Takeaways
Figure 38 North America Market Estimates and Forecasts, 2018-2030
Figure 39 U.S. Market Estimates and Forecasts, 2018-2030
Figure 40 Canada Market Estimates and Forecasts, 2018-2030
Figure 41 Mexico Market Estimates and Forecasts, 2018-2030
Figure 42 Europe Market Estimates and Forecasts, 2018-2030
Figure 43 U.K. Market Estimates and Forecasts, 2018-2030
Figure 44 Germany Market Estimates and Forecasts, 2018-2030
Figure 45 France Market Estimates and Forecasts, 2018-2030
Figure 46 Italy Market Estimates and Forecasts, 2018-2030
Figure 47 Spain Market Estimates and Forecasts, 2018-2030
Figure 48 Denmark Market Estimates and Forecasts, 2018-2030
Figure 49 Sweden Market Estimates and Forecasts, 2018-2030
Figure 50 Norway Market Estimates and Forecasts, 2018-2030
Figure 51 Asia Pacific Market Estimates and Forecasts, 2018-2030
Figure 52 Japan Market Estimates and Forecasts, 2018-2030
Figure 53 China Market Estimates and Forecasts, 2018-2030
Figure 54 India Market Estimates and Forecasts, 2018-2030
Figure 55 Australia Market Estimates and Forecasts, 2018-2030
Figure 56 South Korea Market Estimates and Forecasts, 2018-2030
Figure 57 Thailand Market Estimates and Forecasts, 2018-2030
Figure 58 Latin America Market Estimates and Forecasts, 2018-2030
Figure 59 Brazil Market Estimates and Forecasts, 2018-2030
Figure 60 Argentina Market Estimates and Forecasts, 2018-2030
Figure 61 Middle East & Africa Market Estimates and Forecasts, 2018-2030
Figure 62 South Africa Market Estimates and Forecasts, 2018-2030
Figure 63 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 64 UAE Market Estimates and Forecasts, 2018-2030
Figure 65 Kuwait Market Estimates and Forecasts, 2018-2030

Companies Mentioned

The companies profiled in this Molecular Imaging market report include:
  • Bruker
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Mediso Ltd.
  • Cubresa Inc.
  • Shimadzu Corporation
  • United Imaging Healthcare Co., Ltd.
  • Positron

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.4 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Molecular Imaging Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Molecular Imaging Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Molecular Imaging - Global Strategic Business Report - Product Image

Molecular Imaging - Global Strategic Business Report

  • Report
  • 392 Pages
  • Global
From
Coronary Heart Disease Diagnostic Imaging Device Market Size, Share & Trends Analysis Report by Modality (Computed Tomography, X-rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), Region, and Segment Forecasts, 2025-2030 - Product Image

Coronary Heart Disease Diagnostic Imaging Device Market Size, Share & Trends Analysis Report by Modality (Computed Tomography, X-rays, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine), Region, and Segment Forecasts, 2025-2030

  • Report
  • 190 Pages
  • Global
From
Photoacoustic Tomography Market Size, Share & Trends Analysis Report by Type (Photoacoustic Microscopy, Intravascular Photoacoustic Tomography), Application (Functional Brain Imaging), End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Photoacoustic Tomography Market Size, Share & Trends Analysis Report by Type (Photoacoustic Microscopy, Intravascular Photoacoustic Tomography), Application (Functional Brain Imaging), End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From
Imaging Services Market by Service Type, Modality, Application, End-User - Global Forecast to 2030 - Product Image

Imaging Services Market by Service Type, Modality, Application, End-User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From

About the Molecular Imaging Market

Molecular Imaging is a form of medical imaging that uses specialized imaging techniques to detect and measure the activity of molecules in the body. It is used to diagnose and monitor diseases, such as cancer, cardiovascular disease, and neurological disorders. Molecular Imaging can provide detailed information about the structure and function of cells and tissues, which can help physicians make more informed decisions about treatment. It can also be used to monitor the effectiveness of treatments. Molecular Imaging is used in combination with other imaging modalities, such as X-ray, computed tomography (CT), and magnetic resonance imaging (MRI). It is also used in combination with other diagnostic tests, such as blood tests and biopsies. Some of the companies in the Molecular Imaging market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, Toshiba Medical Systems, Shimadzu Corporation, and Hologic. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.